News

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

May 30, 2024/

A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing clinical trials. The drug is now being given to those with ALS and could be a watershed moment in the treatment of the fatal disease.

By Paul McClure


Click here to read the story.

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

Sorry, we couldn't find any posts. Please try a different search.

MATR Supporters (view all)


For over 25 years, Montana World Trade Center® has served Montana as a trusted business adviser.

Big Sky Commerce is an integrated provider of merchant credit card transaction processing services, check processing services, Internet payment gateways, related software application products and value-added services.

Great Falls trade area. Competitive for food, ag, bioprocessing, energy, and support. Closest U.S. metro area to Calgary. Untame Your Entrepreneurial Spirit!